National Prescribing Indicators 2024-2025: Quarterly reports

The National Prescribing Indicators (NPIs) for 2022-2025 include indicators for primary and secondary care, with a focus on the following priority areas:

• Analgesics (including opioids, tramadol, and gabapentin and pregabalin)
• Anticoagulants in atrial fibrillation
• Antimicrobial stewardship (including total antibacterial items and the ‘4C antimicrobials’: co-amoxiclav, cephalosporins, fluoroquinolones and clindamycin)
• Decarbonisation of inhalers

These four priority areas were supported by additional indicators:

• Safety
  • Prescribing safety indicators
  • Hypnotics and anxiolytics
  • Yellow Cards
• Efficiency
  • Best value biological medicines
  • Low value for prescribing

On a quarterly basis, a report is compiled analysing the performance of each health board against the current set of NPIs.